NCT00000560View on ClinicalTrials.gov

Beta-Blocker Evaluation in Survival Trial (BEST)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1994

Study Completion Date

September 30, 1999

Conditions

Cardiovascular DiseasesHeart DiseasesHeart Failure, CongestiveHeart Failure

Interventions

DRUG

adrenergic beta antagonists

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH